JPRN-UMIN000011454已完成未知
Prospective randomized phase 2 trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy - Prospective randomized phase 2 trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy
Multicenter Clinical Study Group of Osaka0 个研究点目标入组 60 人开始时间: 2013年8月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Severe liver cirrhosis or severe active hepatitis (2) Severe pulmonary disorders (3) Severe renal disorders (4) Active double cancer except carcinoma in situ or intramucosal cancer (synchronous double cancer or asynchronous double cancer with disease-free duration to be within 2 years) (5) Hypersensitivity to eggs (6) As determined by the principal investigator or the sub-investigator the subject is not adequate to participate in the trial.
研究者
相似试验
进行中（未招募）
1 期
FOLFOXIRI with or without panitumumab in metastatic colorectal cancerEUCTR2009-017731-17-DEAIO-Studien-gGmbh93
已完成
不适用
Prospective randomised phase II clinical trial of epirubicin, cisplatin, continuous infusional 5-fluorouracil (ECF) versus epirubicin, cisplatin and capecitabin (ECX) in patients with advanced gastric cancerCancerISRCTN72792659Ministry of Higher Education, Science and Technology (Slovenia)80
已完成
不适用
Phase II randomized clinical trial for the purpose of examining the protective efficacy of the non-alcoholic fatty liver development by pancrelipase preparation being given for pancreatic cancer patients who underwent pancreaticoduodenectomy or total pancreatectomy.To assume the decreased rate of post-operative non-alcoholic fatty liver incidence in pancreatic cancer patients with the prophylactic administration of the pancrelipase preparation.JPRN-UMIN000019817Department of Surgery, Kansai Medical University80
进行中（未招募）
不适用
Randomized prospectic clinical trial Phase II in patients affected by prognostic class RPA V and VI glioblastoma: comparison between hypofractionated radiotherapy (RT) 30 Gy (6 fractions in two weeks) and esclusive temozolomide (TMZ)(200 mg/m2 for 5 days every 28) - AOBS-RT-TMZPatients with histological diagnosis od glioblastoma in RPA class V and VI and age =>65 yrs.MedDRA version: 9.1Level: SOCClassification code 10029104EUCTR2009-016813-11-ITAZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
进行中（未招募）
不适用
A Phase II Randomized Clinical Trial of Panitumumab plus Gemcitabine and Oxaliplatin (GEMOX) versus GEMOX alone as First Line Treatment in Advanced Biliary Tract Adenocarcinoma - Vecti-BIadvanced intrahepatic colangiocarcinoma and extrahepatic biliary adenocarcinoma including gallbladderMedDRA version: 9.1Level: LLTClassification code 10008594MedDRA version: 9.1Level: LLTClassification code 10025943MedDRA version: 9.1Level: LLTClassification code 10061239MedDRA version: 9.1Level: LLTClassification code 10022789EUCTR2009-017428-17-ITAZIENDA OSPEDALIERA ORDINE MAURIZIANO